Squawk Pod: GLPs & fraud with Dr. Oz & Kevin O’Leary’s $11m baseball card - 09/08/26 | Audio Only

Watch on YouTube ↗  |  September 08, 2026 at 17:23  |  38:28  |  CNBC
Speakers
Mehmet Oz — Administrator for the Centers for Medicare and Medicaid Services
Kevin O'Leary — TV Personality, Shark Tank
Andrew Ross Sorkin — Co-Anchor, Squawk Box

Summary

Squawk Pod covers the market fallout from Canadian tariffs and Middle East oil disruption, plus AI and AGI headlines. Dr. Mehmet Oz discusses Medicare drug pricing, GLP-1 coverage expansion, and healthcare fraud. Kevin O'Leary explains his thesis for rare collectibles and shows the $11 million Shohei Ohtani card. The main market implications are pharma policy, obesity drug demand, and alternative collectible assets.

  • Canada's retaliatory tariffs hit US goods and Bombardier shares after Trump's boycott call.
  • Oil prices rise amid Middle East violence and Saudi Aramco/Hormuz concerns.
  • Nvidia and OpenAI AGI headlines highlight AI scaling and control debate.
  • Dr. Oz says most-favored-nation pricing now covers 90% of US branded drugs and boosted pharma market cap.
  • Medicare GLP-1 coverage at $50 a month has enrolled more than 600k and could reduce long-term costs.
  • Dr. Oz details Medicare and Medicaid fraud crackdowns using frontier AI models.
  • Kevin O'Leary argues rare collectibles are an alternative asset class and wants 5% portfolio exposure.
  • O'Leary showcases the $11 million Ohtani one-of-one card and prefers vintage proven cards.
Ideas
Mehmet Oz Administrator for the Centers for Medicare and Medicaid Services 10:58
MFN drug pricing rewards US pharma
The administration's most-favored-nation drug pricing push now covers 90% of branded drugs sold in America. Pharma companies signed voluntarily, the policy is onshoring production, and Oz says the industry's market cap rose after the initial deals; Europe will need to pay up while US innovation is advantaged.
Mehmet Oz Administrator for the Centers for Medicare and Medicaid Services 15:14
Medicare expansion boosts GLP-1 demand
Medicare expansion covers GLP-1 obesity drugs at $50 a month versus over $1,000 historically. More than 600,000 beneficiaries joined in two months, creating massive additional markets, and Oz says these drugs cut diabetes, hypertension, obesity and long-term costs, with data showing costs declining within two years.
Kevin O'Leary TV Personality, Shark Tank 30:04
Index only the very best collectibles
Rare collectibles are an alternative asset class that can outperform the S&P, as shown by a dual logo card bid between $18-21 million after being shown at $12.9 million. O'Leary argues investors should index it by owning many, many, many of only the very best cards, creating diversification like an ETF, and he wants 5% of his portfolio in collectibles. Watches have followed a similar path and rare watches have rebounded.
Kevin O'Leary TV Personality, Shark Tank 32:31
Ohtani one-of-one card stays safe
The Shohei Ohtani one-of-one card is a safe collectible because Ohtani has transcended baseball and is known even by non-fans. The card includes Japanese and English autographs and game-used patches that cannot be replicated, and demand remains strong from other collectors.
Kevin O'Leary TV Personality, Shark Tank 33:16
Prefer vintage Hall of Fame sports cards
Within the collectibles index, O'Leary prefers vintage sports cards of players already in the Hall of Fame whose value has been proven over time and has steadily risen, rather than ultra-modern cards.
Up Next

This CNBC video, published September 08, 2026, features Mehmet Oz, Kevin O'Leary discussing US pharmaceutical industry, GLP-1 obesity drugs, Collectibles, High-end sports cards, Rare watches, Shohei Ohtani collectible card, Vintage sports cards. 5 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Mehmet Oz, Kevin O'Leary  · Tickers: US pharmaceutical industry, GLP-1 obesity drugs, Collectibles, High-end sports cards, Rare watches, Shohei Ohtani collectible card, Vintage sports cards